Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b vaccines after temporary suspension of DMARD therapy in immune-mediated inflammatory disease (RESCUE)면역매개염증질환(RESCUE)에서 DMARD 치료를 일시적으로 중단한 후 COVID-19 ChAdOx1nCov-19 및 BNT162b 백신에 대한 항체 반응Randomized Controlled Trial Published on 2022-05-012022-09-11 Journal: RMD Open [Category] COVID19(2023년), MERS, SARS, 임상, 진단, 치료기술, 치료제, [키워드] Adult patients Antibody Response Antibody responses antirheumatic agents AstraZeneca AZ vaccine baseline biologic BNT162b Control control group control groups controls COVID-19 csDMARD dose Final first and second dose first dose first vaccination group groups IgG Immune-mediated immunogenicity inflammatory disease Messenger RNA multicentre not significantly different Patient Pfizer Protein randomised randomised controlled trial registration number response S1/S2 SARS-CoV-2 antibody SARS-CoV-2 IgG SARS-CoV2 second dose second vaccination Seroconversion seroconversion rate seroconversion rates significantly lower the antibody response the mean therapy titre titres U/mL vaccination Vaccine were measured [DOI] 10.1136/rmdopen-2022-002301 PMC 바로가기 [Article Type] Randomized Controlled Trial
Evaluating the Effect of a COVID-19 Predictive Model to Facilitate Discharge: A Randomized Controlled Trial퇴원을 촉진하기 위한 COVID-19 예측 모델의 효과 평가: 무작위 통제 시험Randomized Controlled Trial Published on 2022-05-012022-09-11 Journal: Applied clinical informatics [Category] COVID19(2023년), SARS, 임상, 치료기술, [키워드] 1:1 adoption Adverse adverse events Algorithm Analysis clinician complex contributed control arm control groups Controlled coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 pandemic death detectable discharge display displaying Effect EHR Electronic health record Evaluating Factor had no Health health record health system help hospice hospital Hospitalized Identifier identify Intervention intervention effect lack LOS Model one health outcome Patient Predictive primary symptom risk risk score Risk scores routine care Safe secondary study period sustained tested Trial with COVID-19 [DOI] 10.1055/s-0042-1750416 PMC 바로가기 [Article Type] Randomized Controlled Trial
Supporting business educators and students against COVID-19 trauma using trauma-focused cognitive behavioral therapyRandomized Controlled Trial Published on 2022-04-082022-10-05 Journal: Medicine [Category] 임상, [키워드] adverse effect Anxiety arising assigned cognitive control groups Coping strategy coronavirus COVID-19 COVID-19 pandemic Depression distress Effect Factor Follow-up Gender indicated Intervention mental health mental health problem Nigeria no significant difference outbreak outcome participant Participants Post-traumatic stress disorder Psychological PTSD questionnaire Randomly reduced repeated measure Research significantly Study participants Support Supporting Symptom therapy trauma Treatment treatment group variance was used [DOI] 10.1097/MD.0000000000029133 PMC 바로가기 [Article Type] Randomized Controlled Trial
Surveillance of Safety of 3 Doses of COVID-19 mRNA Vaccination Using Electronic Health Records전자 건강 기록을 사용한 COVID-19 mRNA 백신 3회 접종의 안전성 감시Article Published on 2022-04-012022-09-12 Journal: JAMA Network Open [Category] COVID19(2023년), SARS, 진단, [키워드] 95% CI addition Administered Adverse adverse event adverse events age analyzed anaphylaxis approval arthralgia BNT162b2 booster vaccination booster vaccinations chill clinical trials Cohort cohort study cohorts comparable conducted control groups COVID-19 COVID-19 mRNA vaccine COVID-19 mRNA vaccines criteria diarrhea dose drug EHR eligible evaluate fatigue Fever food headache Health increased risk individual individuals Mayo Clinic median mRNA mRNA vaccine mRNA-1273 myalgia myocarditis nausea outcome participant profile quantified receiving recent Record regimen remained reported Reporting risk Safety SARS-COV-2 infection second dose severe adverse event study inclusion study participant thrombosis vaccination Vaccine vaccine dose Vaccine-induced immunity venous vomiting was tested were assessed [DOI] 10.1001/jamanetworkopen.2022.7038 PMC 바로가기 [Article Type] Article
Efficacy and Sustainability of Diabetes-Specific Meal Replacement on Obese and Overweight Type-2 Diabetes Mellitus Patients: Study Approaches for a Randomised Controlled Trial and Impact of COVID-19 on Trial ProgressRandomized Controlled Trial Published on 2022-04-012022-10-05 Journal: International Journal of Environmental Research an [Category] 임상, [키워드] approval baseline biochemical both group changes clinical clinical trial Compliance control groups Controlled Cost effectiveness COVID-19 COVID-19 pandemic diabete diabetes diet modification Efficacy evaluate evaluated Follow-up glycaemic control glycemic glycemic control handling HbA1c Health Impact Intervention intervention group management material meal meal replacement MONITOR obese obesity Other outcome outcomes overweight participant patients primary endpoint Progress Quality of life randomised randomised controlled receive reduction Registered registry replacement secondary endpoint Study design sustainability weight loss [DOI] 10.3390/ijerph19074188 PMC 바로가기 [Article Type] Randomized Controlled Trial
The Evaluation of a Social Media Campaign to Increase COVID-19 Testing in Migrant Groups: Cluster Randomized TrialRandomized Controlled Trial Published on 2022-03-242022-10-04 Journal: Journal of Medical Internet Research [Category] 임상, [키워드] 95% CI assigned campaign Cluster cluster randomized trial communication control group control groups COVID-19 COVID-19 pandemic COVID-19 test English Eritrea Facebook follow-up period Government group groups hospitalizations increase increase in individual Intervention intervention group Iraq media migrant Nonpharmaceutical interventions Norway pandemic performed platform Poland predicted Probability public health Randomized Randomly remained Russia SARS-CoV-2 social media Strategy Testing Turkey [DOI] 10.2196/34544 PMC 바로가기 [Article Type] Randomized Controlled Trial
Ivermectin for the Treatment of Coronavirus Disease 2019: A Systematic Review and Meta-analysis of Randomized Controlled Trials코로나바이러스 질병 2019 치료를 위한 이버멕틴: 무작위 대조 시험의 체계적인 검토 및 메타 분석Meta-Analysis Published on 2022-03-232022-09-11 Journal: Clinical Infectious Diseases: An Official Publicat [Category] 임상, [키워드] 95% confidence interval Adult patients adverse event adverse events AEs all-cause mortality all-cause mortality rate all-cause mortality rates benefit Bia confidence interval Control control group control groups Controlled coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 disease COVID-19 disease severity did not reduce Effect evaluated Evidence Hospital stay inverse Ivermectin LOS main analyses mean difference meta-analyses Meta-analysis Mild moderate Mortality mortality rates outcome outcomes Patient patients with COVID-19 performed Placebo Primary outcomes random effect Randomized controlled trial Randomized controlled trials RCT RCTs reduced Relative risk review risk risk of bia RoB SAE SAEs SARS-CoV-2 searched secondary Secondary outcomes severe AE severe AEs severity of COVID-19 Standard of care subgroups treat viral clearance [DOI] 10.1093/cid/ciab591 PMC 바로가기 [Article Type] Meta-Analysis
Effectiveness of tocilizumab in the treatment of hospitalized adults COVID-19: A systematic review and meta-analysis입원한 성인 COVID-19 치료에서 토실리주맙의 효과: 체계적인 검토 및 메타 분석Meta-Analysis Published on 2022-03-042022-09-11 Journal: Medicine [Category] SARS, 임상, 진단, [키워드] 30-Day mortality 95% CI 95% confidence interval Admission Analysis assigned clinical control groups Controlled controlled trials coronavirus coronavirus disease COVID-19 COVID-19 patients death determine discharge Effectiveness hazard ratio Health Health Organization Hospitalized hospitalized COVID-19 patients incidence Infection intensive care intensive care unit admission mechanical ventilation Meta-analysis meta-analysis model Mortality optimal dose outcome Patient performed random-effect Randomized controlled trial Randomized controlled trials Randomly receive reduced registry Relative risk required review risk searched Serious Adverse Event Serious Adverse Events significantly Spread systematic review Tocilizumab Treatment usual care usual care alone was used with COVID-19 World Health Organization [DOI] 10.1097/MD.0000000000028967 PMC 바로가기 [Article Type] Meta-Analysis
Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipientsArticle Published on 2022-03-042022-10-04 Journal: Scientific Reports [Category] SARS, 진단, [키워드] antibody binding domain ChAdOx1 nCoV-19 vaccine control group control groups controls dialysis dose elicited enrolled greater group groups HD group Heterologous immune response immunogenicity inactivated Infectious diseases IQR kidney transplant kidney transplant recipient median Nephrology neutralization parameter participant Patient patients positive recipient remained response SARS-CoV-2 vaccination SARS-CoV-2 vaccine SARS-CoV-2 virus significantly increased T-cell Vaccination strategy [DOI] 10.1038/s41598-022-07574-w PMC 바로가기 [Article Type] Article
Does m-health-based exercise (guidance plus education) improve efficacy in patients with chronic low-back pain? A preliminary report on the intervention’s significanceRandomized Controlled Trial Published on 2022-03-032022-10-04 Journal: Trials [Category] MERS, SARS, 임상, [키워드] analysis of variance Anxiety assigned change Chinese clinical Clinical data control group control groups Controlled trial COVID-19 pandemic Depression disability effective Effectiveness Effects Efficacy Exercise therapy Follow-up Guidance Health Health Education help IMPROVE in both groups intensity Intervention Intervention effects intervention group lack low back pain management Mental Mobile health number Pain participant Patient preliminary report Primary outcomes Quality of life Randomly registry Result Roland scale Secondary outcomes selected significant effect significant interaction therapeutic effect treat Treatment was used [DOI] 10.1186/s13063-022-06116-z PMC 바로가기 [Article Type] Randomized Controlled Trial